Viking Therapeutics, Inc.

Business Summary

of this Annual Report on Form 10-K. The process required by the FDA before drugs may be marketed in the U.S. generally involves the following: completion of non-clinical laboratory tests, animal studies and formulation studies conducted according to good laboratory practice or other applicable regulations; submission of an IND, which must become effective before human clinical trials may be initiated; 15 adequate and well-controlled human clinical trials to establish the safety and efficacy of t...

Next Earnings

Q2 FY2026 — expected 2026-08-21

Key Facts from Earnings Calls

Annual Reports (10-K)

Quarterly Reports (10-Q)

Recent Current Reports (8-K)

196 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

Company Identity

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API: